Generics of the top lung cancer treatment will appear, decreasing the overall drug price down by 38% for the disease

As the patent of the most selling lung cancer treatment ‘Alimta(Lilly Korea)’ will expire on the 10^th next month, generic products with the same substance are about make sales.

It seems that generics, having 38% cheaper drug price against original product, will help reduce both cost of the National Health Service and patients.

According to the pharmaceutical industry on the 22^nd, as the subst...